Users Online: 384
Home
|
About IJT
|
Editorial board
|
Search
|
Ahead of print
|
Current Issue
|
Archives
|
Instructions
|
Online submission
|
Subscribe
|
Advertise
|
Contact us
|
Reader Login
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
Most cited articles *
Archives
Most popular articles
Most cited articles
Show all abstracts
Show selected abstracts
Export selected to
Cited
Viewed
PDF
ORIGINAL ARTICLES
Dermoscopy in female androgenic alopecia: Method standardization and diagnostic criteria
Adriana Rakowska, Monika Slowinska, Elzbieta Kowalska-Oledzka, Malgorzata Olszewska, Lidia Rudnicka
July-December 2009, 1(2):123-130
DOI
:10.4103/0974-7753.58555
PMID
:20927234
Objective:
Establishing the trichoscopy criteria of female androgenic alopecia (FAGA).
Design:
Trichoscopy images were retrospectively evaluated.
Setting:
Dermatologic hospital-based clinic and private practice offices.
Patients and methods:
One hundred and thirty-one females (59 with androgenic alopecia, 33 with chronic telogen effluvium (CTE), 39 healthy controls). The diagnosis was based on clinical examination and confirmed by histopatology.
Main Outcome Measure:
Trichoscopy results obtained in frontal, occipital and both temporal areas of the scalp under a 20-fold and 70-fold magnification, including average hair thickness, number of 'yellow dots' and vellus hairs, number of hairs in one pilosebaceous unit and percentage of follicular ostia with perifollicullar hyperpigmentation.
Results:
Average hair thickness in frontal area versus occiput was, respectively, 0.061 ± 0.008 mm versus 0.058 ± 0.007 mm in healthy controls, 0.047 ± 0.007 mm versus 0.052 ± 0.008 mm in androgenic alopecia and 0.056 ± 0.007 mm versus 0.053 ± 0.009 mm in CTE. Mean percentage of thin hairs (< 0.03 mm) in androgenic alopecia was 20.9 ± 12% and was significantly higher than in healthy controls (6.15 ± 4.6%,
P
< 0.001) or in CTE (10.4 ± 3.9%,
P
< 0.001). The number of yellow dots, pilosebaceous units with only one hair and with perifollicular hyperpigmentation was significantly increased in androgenic alopecia. Classification and Regression Tree Analysis was performed to establish diagnostic criteria for FAGA.
Conclusion:
FAGA may be differentiated from CTE based on trichoscopy criteria. Major criteria are ratio of (1) more than four yellow dots in four images (70-fold magnification) in the frontal area, (2) lower average hair thickness in the frontal area compared to the occiput and (3) more than 10% of thin hairs (below 0.03 mm) in the frontal area. Minor criteria encompass increased frontal to occipital ratio of (1) single-hair pilosebaceous units, (2) vellus hairs and (3) perifollicular discoloration. Fulfillment of two major criteria or one major and two minor criteria allows to diagnose FAGA based on trichoscopy with a 98% specificity.
[ABSTRACT]
[FULL TEXT]
[PDF]
[CITATIONS]
[PubMed]
26
7,119
384
CASE REPORTS
Monilethrix in pattern distribution in siblings: Diagnosis by trichoscopy
Nilam Jain, Uday Khopkar
January-June 2010, 2(1):56-59
DOI
:10.4103/0974-7753.66918
PMID
:21188029
Monilethrix is a heritable hair shaft defect characterized by localized or diffuse alopecia resulting from hair fragility over friction areas, predominantly the temporal and occipital regions, and follicular keratosis over the occipital region. However, it lacks macroscopic features that enable easy and rapid diagnosis in medical practice. Hair shaft microscopy is the basis for diagnosing monilethrix. We present a report of two Indian male siblings aged 24 and 21, who presented with thinning and hair loss from the scalp in male pattern distribution and multiple skin-colored follicular papules over the nape of the neck and bilateral forearms since childhood. Trichoscopy of scalp hair revealed characteristic uniform elliptical nodes and intermittent constrictions along with variation in hair shaft diameter, presence of few vellus hair and yellow dots, suggesting a diagnosis of monilethrix with early-onset androgenetic alopecia. Dermoscopy of the papules revealed multiple stubs of broken hair arising from them with a similar beaded appearance, suggesting a diagnosis of monilethrix. The diagnosis of monilethrix was confirmed with light microscopy and hair clipping. This report highlights the patterned distribution of hair loss in monilethrix probably due to the early unmasking of androgenetic alopecia and the use of trichoscopy as the diagnostic modality.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
14
4,103
92
N-acetylcysteine in the treatment of trichotillomania
Ana Rita Rodrigues-Barata, Antonella Tosti, Antonio Rodríguez-Pichardo, Francisco Camacho-Martínez
July-September 2012, 4(3):176-178
DOI
:10.4103/0974-7753.100090
PMID
:23180931
Trichotillomania is as medical condition caused by the patient himself by pulling out of is own hair, resulting in a perceptible hair loss pattern that frequently is associated with other psychiatric processes. Generally has a chronic course in most patients, and a challenging therapeutical management. There are several available options for is treatment, but the clinical response is not satisfactory in many patients. Recently, N-acetylcisteine, a glutamate modulator, has shown efficacy in the treatment of trichotillomania and other compulsive behaviors, and is considered a new alternative in the management of this condition. We describe two patients with trichotillomania successfully treated with N-acetylcysteine. Nevertheless, further studies need to be conducted to establish the appropriate treatment regimen and to evaluate it long-term efficacy in improving this chronic condition.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
11
6,462
73
ORIGINAL ARTICLE
Randomized comparison of topical betamethasone valerate foam, intralesional triamcinolone acetonide and tacrolimus ointment in management of localized alopecia areata
CM Kuldeep, Himanshu Singhal, Ashok Kumar Khare, Asit Mittal, Lalit K Gupta, Anubhav Garg
January-June 2011, 3(1):20-24
DOI
:10.4103/0974-7753.82123
PMID
:21769231
Background:
Alopecia areata (AA) is a common, non-scarring, patchy loss of hair at scalp and elsewhere. Its pathogenesis is uncertain; however, auto-immunity has been exemplified in various studies. Familial incidence of AA is 10-42%, but in monozygotic twins is 50%. Local steroids (topical / intra-lesional) are very effective in treatment of localized AA.
Aim:
To compare hair regrowth and side effects of topical betamethasone valerate foam, intralesional triamcinolone acetonide and tacrolimus ointment in management of localized AA.
Materials and Methods:
105 patients of localized AA were initially registered but 27 were drop out. So, 78 patients allocated at random in group A (28), B (25) and C (25) were prescribed topical betamethasone valerate foam (0.1%) twice daily, intralesional triamcinolone acetonide (10mg/ml) every 3 weeks and tacrolimus ointment (0.1%) twice daily, respectively, for 12 weeks. They were followed for next12 weeks. Hair re-growth was calculated using "HRG Scale"; scale I- (0-25%), S II-(26-50%), S III - (51-75%) and S IV- (75-100%).
Results:
Hair re-growth started by 3 weeks in group B (Scale I:
P
<0.03), turned satisfactory at 6 weeks in group A and B (Scale I:
P
<0.005, Scale IV:
P
<0.001)), good at 9 weeks (Scale I:
P
<0.0005, Scale IV:
P
<0.00015), and better by 12 weeks of treatment (Scale I:
P
<0.000021, Scale IV:
P
<0.000009) in both A and B groups. At the end of 12 weeks follow-up hair re-growth (>75%, HRG IV) was the best in group B (15 of 25, 60%), followed by A (15 of 28, 53.6%) and lastly group-C (Nil of 25, 0%) patients. Few patients reported mild pain and atrophy at injection sites, pruritus and burning with betamethasone valerate foam and tacrolimus.
Conclusion:
Intralesional triamcinolone acetonide is the best, betamethasone valerate foam is better than tacrolimus in management of localized AA.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
11
8,548
195
ORIGINAL ARTICLES
Reliability of hamilton-norwood classification
M Guarrera, P Cardo, P Arrigo, A Rebora
July-December 2009, 1(2):120-122
DOI
:10.4103/0974-7753.58554
PMID
:20927233
Background:
Hamilton-Norwood scale (HNS) has been largely used to assess clinically the severity of androgenetic alopecia (AGA), especially for therapeutical trials and even to establish its association with important diseases such as ischemic heart disease and prostate cancer.
Objective
: To study HNS reproducibility in the hands of dermatologists and dermatology residents.
Materials and
Methods:
Seven dermatologists and 16 residents in dermatology classified 43 photographs of male heads with different degrees of AGA. In a second study, 8 appraisers (3 dermatologists and 5 residents in dermatology) examined 56 pictures with the same procedure and repeated the observation 3 months later. In the first study, the inter-rater agreement was estimated by calculating an intra-class correlation coefficient (ICC). In the second study, for intra-rater repeatability, each rater's scores from session 1 were paired with his/her scores for the same subjects in session 2, and the ordinary least products linear regression was calculated.
Results:
In the first study, the concordance of appraisers was unsatisfactory (ICC = 0.63-0.68)]. In the second study, repeatability was poor, without any significant difference between dermatologists and dermatology residents.
Comment:
Reliability of HNS is unsatisfactory even in the hands of expert appraisers. To obtain better reliability, the number of classes should be reduced, but with such reduction HNS would be usable to classify patients only in a broad way.
[ABSTRACT]
[FULL TEXT]
[PDF]
[CITATIONS]
[PubMed]
10
3,060
162
REVIEW ARTICLES
Topical immunotherapy in alopecia areata
Gurcharan Singh, MS Lavanya
January-June 2010, 2(1):36-39
DOI
:10.4103/0974-7753.66911
PMID
:21188022
Alopecia Areata (AA) is a common non-scarring alopecia directed against the anagenic hair follicle. Various treatment modalities have been used for the treatment of severe AA. Topical immunotherapy is the best documented treatment so far for severe and refractory AA. Dinitrochlorobenzene (DNCB), squaric acid dibutylester (SADBE), and diphencyprone (DPCP) are the contact allergens used for this purpose. DNCB has been found to be mutagenic by the Ames test and is largely replaced by DPCP and SADBE. DPCP and SADBE are both known to be non-mutagenic compounds and have comparable efficacy results and relapse rates. SADBE requires special solvents and additives to maintain its potency and is more expensive than the rest. DPCP has a response rate varying from 60% in severe Alopecia Areata to 17% in patients with alopecia totalis or universalis, and shows about 88 to 100% high response rate in patients with patchy Alopecia Areata.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
10
6,906
358
Oxidative stress in ageing of hair
Ralph M Trueb
January-June 2009, 1(1):6-14
DOI
:10.4103/0974-7753.51923
PMID
:20805969
Experimental evidence supports the hypothesis that oxidative stress plays a major role in the ageing process. Reactive oxygen species are generated by a multitude of endogenous and environmental challenges. Reactive oxygen species or free radicals are highly reactive molecules that can directly damage cellular structural membranes, lipids, proteins, and DNA. The body possesses endogenous defence mechanisms, such as antioxidative enzymes and non-enzymatic antioxidative molecules, protecting it from free radicals by reducing and neutralizing them. With age, the production of free radicals increases, while the endogenous defence mechanisms decrease. This imbalance leads to the progressive damage of cellular structures, presumably resulting in the ageing phenotype. Ageing of hair manifests as decrease of melanocyte function or graying, and decrease in hair production or alopecia. There is circumstantial evidence that oxidative stress may be a pivotal mechanism contributing to hair graying and hair loss. New insights into the role and prevention of oxidative stress could open new strategies for intervention and reversal of the hair graying process and age-dependent alopecia.
[ABSTRACT]
[FULL TEXT]
[PDF]
[CITATIONS]
[PubMed]
10
12,701
628
REVIEW ARTICLE
Loose anagen hair syndrome
Rachita P Dhurat, Deepal J Deshpande
July-December 2010, 2(2):96-100
DOI
:10.4103/0974-7753.77513
PMID
:21712911
Loose anagen syndrome (LAS) is a benign, self-limiting condition where anagen hairs are easily and painlessly extracted. It is mainly reported in childhood; however, it may variably present in adulthood as well. The presence of anagen hair devoid of its sheath and with 'floppy sock appearance' is a characteristic feature of loose anagen hair (LAH) on trichogram. LAH can be seen in normal population and in alopecia areata. The percentage of LAH in LAS is more than 50%. The histopathological findings show clefting between the layers of hair and are very useful in differentiating LAS from alopecia areata. Here, a review on the diagnostic criteria and practical guidelines are discussed so as to enable the trichologist in managing this benign, self-limiting condition and differentiating it from the other causes of non-scarring alopecias.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
9
8,371
177
REVIEW ARTICLES
Hair evaluation methods: Merits and demerits
Rachita Dhurat, Punit Saraogi
July-December 2009, 1(2):108-119
DOI
:10.4103/0974-7753.58553
PMID
:20927232
Various methods are available for evaluation (for diagnosis and/or quantification) of a patient presenting with hair loss. Hair evaluation methods are grouped into three main categories: Non-invasive methods (e.g., questionnaire, daily hair counts, standardized wash test, 60-s hair count, global photographs, dermoscopy, hair weight, contrasting felt examination, phototrichogram, TrichoScan and polarizing and surface electron microscopy), semi-invasive methods (e.g., trichogram and unit area trichogram) and invasive methods (e.g., scalp biopsy). Any single method is neither 'ideal' nor feasible. However, when interpreted with caution, these are valuable tools for patient diagnosis and monitoring. Daily hair counts, wash test, etc. are good methods for primary evaluation of the patient and to get an approximate assessment of the amount of shedding. Some methods like global photography form an important part of any hair clinic. Analytical methods like phototrichogram are usually possible only in the setting of a clinical trial. Many of these methods (like the scalp biopsy) require expertise for both processing and interpreting. We reviewed the available literature in detail in light of merits and demerits of each method. A plethora of newer methods is being introduced, which are relevant to the cosmetic industry/research. Such methods as well as metabolic/hormonal evaluation are not included in this review.
[ABSTRACT]
[FULL TEXT]
[PDF]
[CITATIONS]
[PubMed]
9
9,129
888
BRIEF COMMUNICATION
Finasteride induced gynecomastia: Case report and review of the literature
Yuval Ramot, Tali Czarnowicki, Abraham Zlotogorski
January-June 2009, 1(1):27-29
DOI
:10.4103/0974-7753.51930
PMID
:20805972
Finasteride (1 mg/day) is widely utilized by dermatologists for the treatment of androgenetic alopecia. Although enjoying a relatively good safety profile, several sex-related adverse effects have been reported with this drug. Here we report two cases of gynecomastia, one of them bilateral, caused by Propecia
®
prescribed for the treatment of androgenetic alopecia. Although relatively rare, physicians should be aware of this side effect and inform their patients when prescribing this medication.
[ABSTRACT]
[FULL TEXT]
[PDF]
[CITATIONS]
[PubMed]
8
7,256
259
ORIGINAL ARTICLES
Bimatoprost in the treatment of eyelash universalis alopecia areata
Teresa Ojeda Vila, Francisco M Camacho Martinez
July-December 2010, 2(2):86-88
DOI
:10.4103/0974-7753.77511
PMID
:21712909
Objectives:
To evaluate topical bimatoprost for eyelash growth in patients with alopecia areata (AA).
Design:
A 1-year retrospective study, bilateral eyelash alopecia.
Materials and Methods:
Forty-one subjects with AA universalis without ocular disease applied 0.03% bimatoprost to the eyelid margin once a day over the course of 1 year.
Results:
Thirty-seven subjects completed the study, one patient was eliminated due to conjunctivitis at the beginning of treatment, two patients developed conjunctivitis after 6 months of treatment, and a fourth did not follow directions. Researchers evaluated patients' eyelash growth every 4 months. We observed complete growth in 24.32%, moderate growth in 18.91%, slight growth in 27.02% and without response in 29.72%.
Conclusion:
Bimatoprost may be effective and safe in the treatment of eyelash AA. 43.24% of the patients had an acceptable cosmetic response (total and moderate growth). Limitations: Design without control.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
8
9,196
145
Effective treatment of folliculitis decalvans using selected antimicrobial agents
Caulloo Sillani, Zhang Bin, Zhao Ying, Cai Zeming, Yang Jian, Zhang Xingqi
January-June 2010, 2(1):20-23
DOI
:10.4103/0974-7753.66908
PMID
:21188019
Folliculitis Decalvans (FD) is a rare neutrophilic infammation of the scalp characterized by painful, recurrent purulent follicular exudation resulting in primary cicatricial alopecia. However, unclear etiology makes FD treatment a difficult task. A wide variety of topical and systemic agents have been tried previously, with varied results. We present here a case series report of a set of 13 patients with FD on antimicrobial therapy.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
7
9,826
167
Automated digital image analysis (TrichoScan
®
) for human hair growth analysis: Ease versus errors
Punit P Saraogi, Rachita S Dhurat
January-June 2010, 2(1):5-13
DOI
:10.4103/0974-7753.66905
PMID
:21188016
Background
: TrichoScan
®
is considered to be time-saving, easy to perform and consistent for quantifying hair loss/growth. Conflicting results of our study lead us to closely observe the image analysis, and certain repeated errors in the detection of hair were highlighted. Aims: To assess the utility of TrichoScan in quantification of diffuse hair loss in males with androgenetic alopecia (AGA) and females with diffuse telogen hair loss, with regard to total hair density (THD), telogen and vellus hair percentages.
Materials and Methods
: TrichoScan procedure was performed on 77 cases and 20 controls.
Results and Discussion
: In the cases, THD decreased with increasing severity of alopecia. Surprisingly, more than 85% of the healthy volunteers had an unexplained abnormal telogen hair percentage of more than 20. Also, the telogen hair percentages were not significantly different between cases and controls. Also, 65% of the patients with advanced thinning of hair did not have the expected elevation of vellus hair percentages on TrichoScan evaluation. Multiple errors were highlighted in hair detection by the software. Errors were noted at the exit points of follicular ostia, at places where hair strand thickness was not uniform throughout its length, where there was crossing, overlapping of the neighboring strands, and when more than one hair emerged from a single ostium.
Conclusion
: TrichoScan is promoted as a validated and precise tool for measurement of hair growth parameters. Under certain conditions, it may seem suitable for clinical trials evaluating treatment response. We provide evidence that this is an overstatement. This study concludes that TrichoScan-analyzed anagen/telogen hair detection is not optimal; moreover, there is overestimation of THD and the vellus hair percentage does not correlate with clinical severity of alopecia. The current form of TrichoScan, though easy to use, is error-prone and awaits refinement.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
6
5,077
279
Value of trichoscopy versus trichogram for diagnosis of female androgenetic alopecia
Nadja A Galliker, Ralph M Trüeb
January-March 2012, 4(1):19-22
DOI
:10.4103/0974-7753.96080
Background:
Female androgenetic alopecia (FAGA) is a frequent cause of hair loss in women. Standard diagnostic methods are clinical inspection, pull test, and trichogram. It has been suggested that scalp dermoscopy (trichoscopy) revealing diversity of hair shaft diameter >20% is diagnostic of FAGA.
Objective:
To evaluate the value of trichoscopy as compared to the trichogram for the diagnosis of FAGA.
Patients and Methods:
Retrospective case study of 162 women with the complaint of hair loss who underwent trichoscopic examination and trichograms.
Results:
Of all women diagnosed FAGA (55%), 62% were diagnosed by trichogram, 72% by trichoscopy with a cut-off point of 20%, and 100% irrespective of the degree of diversity of hair shaft diameter.
Conclusions:
Trichoscopy is a valuable and superior method to the trichogram for diagnosis of FAGA, especially in early cases, with the highest yield irrespective of the suggested cut-off of 20% diversity of hair shaft.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
6
7,144
235
REVIEW ARTICLE
Pressure alopecia
Kate E Davies, PD Yesudian
April-June 2012, 4(2):64-68
DOI
:10.4103/0974-7753.96901
PMID
:23180911
Postoperative or pressure alopecia (PA) is an infrequently reported group of scarring and non-scarring alopecias. It has been reported after immobilization of the head during surgery and following prolonged stays on intensive care units, and may be analogous to a healed pressure ulcer. This review presents a summary of cases published in pediatrics and after cardiac, gynecological, abdominal and facial surgeries. PA may manifest as swelling, tenderness, and ulceration of the scalp in the first few postoperative days; in other cases, the alopecia may be the presenting feature with a history of scalp immobilization in the previous four weeks. The condition may cause considerable psychological distress in the long term. Regular head turning schedules and vigilance for the condition should be used as prophylaxis to prevent permanent alopecia. A multi-center study in high-risk patients would be beneficial to shed further light on the etiology of the condition.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
6
5,365
102
REVIEW ARTICLES
Aging of the hair follicle pigmentation system
Desmond J Tobin
July-December 2009, 1(2):83-93
DOI
:10.4103/0974-7753.58550
PMID
:20927229
Skin and hair phenotypes are powerful cues in human communication. They impart much information, not least about our racial, ethnic, health, gender and age status. In the case of the latter parameter, we experience significant change in pigmentation in our journey from birth to puberty and through to young adulthood, middle age and beyond. The hair follicle pigmentary unit is perhaps one of our most visible, accessible and potent aging sensors, with marked dilution of pigment intensity occurring long before even subtle changes are seen in the epidermis. This dichotomy is of interest as both skin compartments contain melanocyte subpopulations of similar embryologic (i.e., neural crest) origin. Research groups are actively pursuing the study of the differential aging of melanocytes in the hair bulb versus the epidermis and in particular are examining whether this is in part linked to the stringent coupling of follicular melanocytes to the hair growth cycle. Whether some follicular melanocyte subpopulations are affected, like epidermal melanocytes, by UV irradiation is not yet clear. A particular target of research into hair graying or canities is the nature of the melanocyte stem compartment and whether this is depleted due to reactive oxygen species-associated damage, coupled with an impaired antioxidant status, and a failure of melanocyte stem cell renewal. Over the last few years, we and others have developed advanced
in
vitro
models and assay systems for isolated hair follicle melanocytes and for intact anagen hair follicle organ culture which may provide research tools to elucidate the regulatory mechanisms of hair follicle pigmentation. Long term, it may be feasible to develop strategies to modulate some of these aging-associated changes in the hair follicle that impinge particularly on the melanocyte populations.
[ABSTRACT]
[FULL TEXT]
[PDF]
[CITATIONS]
[PubMed]
6
9,694
539
CASE REPORTS
An extraordinary colocalization of alopecia areata and vitiligo
Yuval Ramot, Elena Thomaidou, Alexander Mali, Abraham Zlotogorski
July-December 2010, 2(2):108-109
DOI
:10.4103/0974-7753.77522
PMID
:21712899
Although the association of alopecia areata (AA) and vitiligo occurring in the same patient has been frequently reported in the literature, the colocalization of AA and vitiligo is very rare. We report for the first time an adult patient with anatomic concurrence of AA and vitiligo on the scalp. Even though both AA and vitiligo are thought to have the same underlying pathophysiologic mechanisms, the striking rarity of their colocalization challenges this postulated common pathogenesis, and raises the question if autoimmunity is responsible for only a fraction of AA or vitiligo.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
5
4,914
49
Malherbe's calcifying epithelioma (pilomatrixoma): An uncommon periocular tumor
Mohammad Javed Ali, Santosh G Honavar, Milind N Naik, Geeta K Vemuganti
January-June 2011, 3(1):31-33
DOI
:10.4103/0974-7753.82134
PMID
:21769234
Benign calcifying epithelioma of Malherbe or pilomatrixoma or pilomatricoma is an uncommon lesion of the periocular tissues, arising from the matrix cells at the base of the hair. In the periocular area, it usually arises from the lids and eyebrows. Pilomatrixoma has certain characteristic clinical and histopathologic features, but since it is not commonly suspected preoperatively, certain distinctive clinical features of tumor should suggest clinical diagnosis followed by histopathologic confirmation.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
5
5,250
43
Trichoscopy and histopathology of follicular keratotic plugs in scalp discoid lupus erythematosus
Emma Lanuti, Mariya Miteva, Paolo Romanelli, Antonella Tosti
January-March 2012, 4(1):36-38
DOI
:10.4103/0974-7753.96087
Dermoscopy has become an integral part of diagnosing scalp disorders including discoid lupus erythematosus (DLE). Follicular keratotic plugs are a marker of DLE and correlate with the hyperkeratosis and plugging of the follicular ostia with keratotic material. They may be present in acute or chronic lesions and their presence alone or in conjunction with other described dermoscopic features can lead to timely diagnosis and initiation of treatment. We present three cases of scalp DLE and discuss the clinical, dermoscopic and histopathologic features.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
5
9,894
101
ORIGINAL ARTICLES
Extensive alopecia areata: Not necessarily recalcitrant to therapy!
Deepal Deshpande, Rachita Dhurat, Punit Saraogi, Sunil Mishra, Chitra Nayak
July-December 2011, 3(2):80-83
DOI
:10.4103/0974-7753.90807
PMID
:22223966
Background:
Extensive alopecia areata includes alopecia universalis, alopecia totalis, ophiasis and patients having more than 50% scalp involvement. Alopecia universalis (AU) and totalis (AT) are considered to be resistant to single modalities of treatment. Our study highlights the efficacy and safety of combination therapy in extensive alopecia areata.
Aim:
To evaluate the efficacy and safety of a combination treatment with oral bethametasone mini-pulse, topical minoxidil and short contact anthralin in long-standing, treatment-resistant, extensive alopecia areata.
Materials and Methods:
Fifteen patients aged 7 to 45 years with extensive, treatment-resistant alopecia areata (AU: 7; AT: 1; ophiasis: 4; patients with more than 50% scalp involvement: 3) were treated with betamethasone oral mini-pulse (0.1 mg per kg body weight per dose on two consecutive days per week) along with short contact anthralin (1.15%) and 2-5% minoxidil lotion daily, till response. The response was assessed by the severity of alopecia tool (SALT) score. Cosmetic response was defined as regrowth obviating the need of a wig. Failure of treatment was defined as no growth or vellus hair on the scalp.
Results:
Out of eight patients with AU/AT, two attained cosmetic response as early as three months, two at six months and one had partial response. Cosmetic response was attained in all four patients with ophiasis and all three patients with more than 50% scalp involvement at six months. All responders maintained their response without systemic steroids beyond 12 months. Among a total of twelve responders (80%), two with AU showed a mild relapse and were effectively treated with intralesional steroids. Side effects to therapy were mild and reversible.
Conclusion:
A combination therapy of oral steroid minipulse with topical anthralin and minoxidil acts synergistically, being effective as well as safe in treatment-resistant, extensive, long-standing alopecia areata.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
5
10,013
200
The role of bimatoprost eyelash gel in chemotherapy-induced madarosis: An analysis of efficacy and safety
Carrie L Morris, SS Stinnett, JA Woodward
July-December 2011, 3(2):84-91
DOI
:10.4103/0974-7753.90809
PMID
:22223967
Objectives:
Breast cancer patients suffer from madarosis (loss of eyelashes) due to chemotherapy side effects. An effective treatment or prevention for alopecia or madarosis induced by chemotherapy is not available. Potential drug side effects of bimatoprost solution include increased eyelash length, darkness, and number. A formulation of bimatoprost which maximizes eyelash enhancement and minimizes intraocular and systemic side effects has not been reported.
Materials and Methods:
An Institutional Review Board (IRB) and Investigational New Drug (IND) approved, randomized, single-blinded, prospective, internally controlled trial compared bimatoprost eyelash gel in relation to eyelash enhancement of madarosis patients. Forty eyelids of 20 chemotherapy-treated breast cancer patients were randomized to treatment or control (fellow eyelid). Both patient and surgeon (blindly) evaluated bimatoprost gel's effectiveness in improving eyelash appearance at baseline and at monthly intervals.
Results:
The median follow-up time was 3 months (range 1-4). There was a significant difference between treated and fellow eyelash length during month 2 [1.00 mm (
P=
0.004)] and month 3 [1.00 mm,
P=
0.02)], in eyelash pigment [month 1 (2.5,
P=
0.04); month 2 (2,
P=
0.0009); month 3 (3,
P=
0.06)] and thickness [month 2 (2,
P=
0.002); month 3 (3,
P=
0.01)]. There was an improvement in the patient satisfaction scale from baseline 16 (median, range 7-21) to 26 (median, range 17-33,
P=
0.002) at last follow-up.
Conclusions:
Bimatoprost eyelash gel appears promising for chemotherapy-induced madarosis. Patients may find the effects restorative and cosmetically enhancing.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
5
5,441
48
REVIEW ARTICLES
Photoaggravation of hair aging
Won-Soo Lee
July-December 2009, 1(2):94-99
DOI
:10.4103/0974-7753.58551
PMID
:20927230
Photoaggravation of hair aging includes various chemical and physical changes in fiber properties which lead to an increase in fiber porosity, loss of mechanical strength and an increase in surface roughness. These changes come from lipid oxidation, disulfide bond cleavage, tryptophan degradation and cysteic acid formation. Hair exposed to sunlight is claimed to be more brittle, stiffer and drier than before irradiation and exhibits a reduced water-absorption capacity. Hair pigments function to provide photochemical protection to hair proteins. Hair pigments accomplish this protection by absorbing and filtering the impinging radiation and subsequently dissipating this energy as heat. However, in the process of protecting the hair proteins from light, the pigments are degraded or bleached. Dark hair is more resistant to photodegradation than light hair, because of the higher photostability of eumelanin compared to pheomelanin. Integral lipids of hair fibers are degraded by ultraviolet light, as well as by visible light, helping to explain the weakening of the cell membrane complex exposed to light radiation.
[ABSTRACT]
[FULL TEXT]
[PDF]
[CITATIONS]
[PubMed]
5
4,375
207
ORIGINAL ARTICLES
Male androgenetic alopecia: Population-based study in 1,005 subjects
DS Krupa Shankar, M Chakravarthi, Rachana Shilpakar
July-December 2009, 1(2):131-133
DOI
:10.4103/0974-7753.58556
PMID
:20927235
Context:
Male androgenetic alopecia (AGA) is a common condition. There is limited information on its prevalence and patterns.
Aims:
(1). To find the prevalence and most common pattern (2). To correlate the age and pattern of alopecia.
Settings and Design:
Population-based study.
Materials and Methods:
This is a population-based study from the public. The selection was random. The method involved was asking the age and, if found to between 30 and 50 years, the scalp was examined for alopecia and the pattern was determined using the Hamilton Norwood classification.
Results:
Of 1,005 subjects, the youngest was 30 years old and the oldest 49 years old, with a mean age of 37.05 6 standard deviation 4.79. 39.2% of the subjects were in the age group of 30-35, 34.4% in the 36-40 year age group, 26.0% in the 41-45 years age group and 0.4% in the 46-50 years age group. Five hundred and eighty-three subjects (58%) had AGA, the most common type being grade II (27.27%) followed by grade I (22.12%) and grade III (21.78%). 47.5% (
P
= 0.003) had pattern alopecia in the 30-35 years age group, 58.7% in the 36-40 years age group (
P
= 0.8) and 73.2% in the 41-45 years age group (
P
≤ 0.001). In the 30-35 years age group, grade I was 51.18%, grade II was 42.77% and grade VI was 18.52%. In the 41-45 years age group, grade I was 13.38%, grade III was 33.85% and grade VI was 66.67%.
Conclusions:
Fifty-eight percent of the male population aged 30-50 years had AGA. Its grade increased with increase in age. 12.9% of the male population had grades IV to VI, and would benefit from hair transplantation while 44.1% had grades I to III and are potential candidates for medical treatment
[ABSTRACT]
[FULL TEXT]
[PDF]
[CITATIONS]
[PubMed]
4
4,483
282
REVIEW ARTICLES
A new postulate on two stages of dandruff: A clinical perspective
Frederick Manuel, S Ranganathan
January-June 2011, 3(1):3-6
DOI
:10.4103/0974-7753.82117
PMID
:21769228
Dandruff (pityriasis capitis, seborrheic dermatitis confined to the scalp) is a disease that has been around for centuries despite several treatment options. Almost every day new players are entering the market with various antidandruff products, perhaps due to an increase in the incidence of dandruff all over the world. Interestingly, clinicians, especially dermatologists, gave little attention to this problem. At the end, the dandruff sufferer is puzzled by the array of antidandruff products with varied claims entering the market day by day. Why have we not achieved complete treatment success against dandruff? Is dandruff a disease or disorder? It seems that our understanding about dandruff perfectly fits into the famous saying of Albert Einstein, "as the area of light increases, so does the circumferences of darkness." Have dermatologists left dandruff unattended, only to be exploited by the personal care industry?
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
4
6,641
228
Endocrinology of hirsutism
Daisy Kopera, Elisabeth Wehr, Barbara Obermayer-Pietsch
January-June 2010, 2(1):30-35
DOI
:10.4103/0974-7753.66910
PMID
:21188021
Hirsutism represents a primary clinical indicator of androgen excess. The most common endocrine condition causing hirsutism is polycystic ovary syndrome (PCOS). Diagnosing PCOS is not easy as the signs and symptoms are heterogenous. The newest diagnostic guideline made by the Androgen Excess and PCOS Society in 2006, claims the presence of hyperandrogenism, and ovarian dysfunction (oligo / anovulation and / or polycystic ovaries). Obesity associated reproductive and metabolic dysfunctions may aggravate the symptoms of PCOS. PCOS might be underdiagnosed in non obese women because lean PCOS phenotypes might be underestimated for the syndrome. Effective medical treatment of PCOS and associated hirsutism depends on the endocrinological expertise and experience of the therapist in each individual case. An algorithm for the treatment has not been established yet.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
[CITATIONS]
[PubMed]
4
5,551
270
* Source: CrossRef
Feedback
Subscribe
Advertise
Sitemap
|
What's New
|
Feedback
|
Disclaimer
© International Journal of Trichology | Published by Wolters Kluwer -
Medknow
>
Online since 10
th
March, 2009